Insomnia Self-Assessment Tool

Insomnia is the most common sleep disorder on the planet — affecting roughly 1 in 3 adults in any given year, and meeting criteria for chronic insomnia disorder in about 10–15%. But most people who struggle to fall asleep, wake up at 3 AM, or feel unrefreshed in the morning have never been formally evaluated. This insomnia self-assessment tool fills that gap. It mirrors the Insomnia Severity Index (ISI), the most widely used research-grade insomnia screener, and aligns with the diagnostic criteria for insomnia disorder defined in DSM-5 and the International Classification of Sleep Disorders, Third Edition (ICSD-3).

The questions probe four clinical anchors: difficulty initiating sleep (sleep onset latency), difficulty maintaining sleep (nocturnal awakenings), early morning awakening, and the daytime consequences — fatigue, mood disturbance, cognitive slowing, social impairment. A composite score then tells you whether your symptoms fall into the no-clinical-insomnia, sub-threshold, moderate, or severe range.

Each question scores from 0 (no problem) to 4 (very severe). The seven items cover: trouble falling asleep, trouble staying asleep, problems waking too early, satisfaction with current sleep, interference with daily functioning, noticeability of impairment to others, and overall worry/distress about sleep. The total maps to a clinically validated severity band, the same one used in landmark CBT-I trials and meta-analyses.

• 0–7 — No clinically significant insomnia.
• 8–14 — Sub-threshold insomnia (worth tracking; lifestyle interventions usually sufficient).
• 15–21 — Moderate clinical insomnia (CBT-I strongly indicated).
• 22–28 — Severe clinical insomnia (CBT-I plus medical evaluation strongly indicated).

A high score on the questionnaire alone is not a diagnosis. Chronic insomnia disorder, per DSM-5, additionally requires that the symptoms (a) occur at least three nights per week, (b) persist for at least three months, (c) cause clinically significant daytime distress or impairment, and (d) occur despite adequate opportunity for sleep. The tool flags whether your reported pattern meets all four criteria.

Spielman's 3-P behavioral model — Predisposing, Precipitating, and Perpetuating factors — is the conceptual backbone of CBT-I. Predisposing factors include genetics, hyperarousal traits, and family history. Precipitating factors are the trigger — a job loss, bereavement, a medical event, a new baby. Perpetuating factors are the behaviors that turn a 2-week sleep blip into a 2-year insomnia disorder: spending more time in bed, sleeping in on weekends, daytime napping, late-evening alcohol, and clock-watching.

Cognitive Behavioral Therapy for Insomnia (CBT-I) is the first-line treatment recommended by the American Academy of Sleep Medicine (AASM) and the American College of Physicians for chronic insomnia in adults. It is delivered in 4–8 weekly sessions and consists of five integrated components.

1. Sleep restriction therapy — temporarily compressing time in bed to consolidate sleep and rebuild homeostatic drive.
2. Stimulus control — re-pairing the bed with sleep only (no scrolling, no working, no clock-watching).
3. Cognitive restructuring — challenging catastrophic thoughts ('If I don't sleep tonight my whole week is ruined').
4. Sleep hygiene — temperature, light, caffeine, alcohol, exercise, screens.
5. Relaxation training — paced breathing, progressive muscle relaxation, or body-scan meditation.

These features point to obstructive sleep apnea, narcolepsy, parasomnias, or major depression — all of which require diagnosis-specific care. Use this tool's apnea screener and the Epworth Sleepiness Scale alongside the insomnia questionnaire to triage.

Is this tool a medical diagnosis?

No. It's a validated screening instrument that mirrors the Insomnia Severity Index. A formal diagnosis of chronic insomnia disorder requires a clinician — but the score is reliable enough to drive a confident next step.

How long until CBT-I works?

Most patients see meaningful change within 2–3 weeks; full response typically by week 6–8. The first 1–2 weeks of sleep restriction can transiently worsen sleepiness, which is expected and tells the protocol it's working.

Are sleeping pills safe long-term?

Z-drugs and benzodiazepines are second-line and generally not recommended for chronic insomnia beyond a few weeks. They carry tolerance, dependence, fall, and cognitive risks — particularly in older adults — and rebound insomnia on discontinuation.